Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time


The U.S. National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine show that Gilead Sciences Inc's remdesivir is effective at helping COVID-19 patients recover. (Reuters Top News) More More

Similar stories

Lancet, NEJM retract Covid-19 studies that sparked backlash - STAT

Lancet, NEJM retract Covid-19 studies that sparked backlash  STAT

Posted on 4 June 2020 | 3:27 pm | Google News

Coronavirus tracker: GSK, Sanofi burned by Warp Speed picks; EU members launch COVID vax alliance - FiercePharma

Coronavirus tracker: GSK, Sanofi burned by Warp Speed picks; EU members launch COVID vax alliance  FiercePharma

Posted on 4 June 2020 | 8:30 am | Google News

Dalmia Healthcare starts clinical trials to study efficacy of ayurvedic drug for COVID-19 - ETHealthworld.com

Dalmia Healthcare starts clinical trials to study efficacy of ayurvedic drug for COVID-19  ETHealthworld.com

Posted on 4 June 2020 | 8:20 am | Google News

UPDATED: Remdesivir Shows Promise for COVID-19, but Not a Game Changer - POZ

UPDATED: Remdesivir Shows Promise for COVID-19, but Not a Game Changer  POZ

Posted on 3 June 2020 | 1:45 pm | Google News

Covid-19 plasma therapy safe, without adverse side effects: Study - ETHealthworld.com

Covid-19 plasma therapy safe, without adverse side effects: Study  ETHealthworld.com

Posted on 3 June 2020 | 4:22 am | Google News

Why ICMR continues to stand firm on using hydroxychloroquine as prophylaxis - ETHealthworld.com

Why ICMR continues to stand firm on using hydroxychloroquine as prophylaxis  ETHealthworld.com

Posted on 3 June 2020 | 3:16 am | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info